CTOTC‐08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients-Reference-Cited by-同舟云学术

CTOTC‐08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients

Published:2021-11-05 Issue:1 Volume:22 Page:230-244
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American J Transplantation

Author:

Sweet Stuart C.¹^ORCID,Armstrong Brian²,Blatter Joshua¹^ORCID,Chin Hyunsook²,Conrad Carol³^ORCID,Goldfarb Samuel⁴,Hayes Don⁵,Heeger Peter S.⁶^ORCID,Lyou Victoria⁶,Melicoff‐Portillo Ernestina⁷^ORCID,Mohanakumar Thalachallour⁸^ORCID,Odim Jonah⁹,Ravichandran Ranjithkumar⁸,Schecter Marc¹⁰^ORCID,Storch Gregory A.¹,Visner Gary¹¹,Williams Nikki M.⁹,Danziger‐Isakov Lara⁵^ORCID

Affiliation:

1. Washington University in St. Louis St. Louis Missouri

2. Rho Federal Systems Durham North Carolina

3. Lucile Packard Children's Hospital/Stanford Children's Health Palo Alto California

4. Masonic Children's Hospital University of Minnesota Minneapolis Minnesota

5. Cincinnati Children's Hospital Medical Center Cincinnati Ohio

6. Department of Medicine Translational Transplant Research CenterIcahn School of Medicine at Mount Sinai New York New York

7. Texas Children's Hospital Houston Texas

8. Norton Thoracic InstituteSt. Joseph's Hospital and Medical Center Phoenix Arizona

9. NIAIDNational Institutes of Health Bethesda Maryland

10. University of Florida College of Medicine Gainesville Florida

11. Boston Children’s Hospital Boston Massachusetts